Novel Mechanisms of Resistance to Endocrine Therapy: Genomic and Nongenomic Considerations

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Cancer Research

• Publication date

  2006-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-05-2110PMID 16467116
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signaling regulation of genomic and nongenomic functions of estrogen receptors.

  2006cited by this paper
• Functional implications of altered subcellular localization of PELP1 in breast cancer cells.

  2005cited by this paper
• Integration of the extranuclear and nuclear actions of estrogen.

  2005cited by this paper
• Functional regulation of oestrogen receptor pathway by the dynein light chain 1

  2005cited by this paper
• Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes.

  2005cited by this paper
• Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.

  2005cited by this paper
• The modulator of nongenomic actions of the estrogen receptor (MNAR) regulates transcription-independent androgen receptor-mediated signaling: evidence that MNAR participates in G protein-regulated meiosis in Xenopus laevis oocytes.

  2005cited by this paper
• Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.

  2005cited by this paper
• Developmental expression of MNAR mRNA in the mouse brain

  2005cited by this paper
• Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.

  2004cited by this paper
• The Transcriptional Corepressor, PELP1, Recruits HDAC2 and Masks Histones Using Two Separate Domains*

  2004cited by this paper
• The biological role of estrogen receptors α and β in cancer

  2004cited by this paper
• Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes.

  2004cited by this paper
• Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: Role in epithelial cancer cell invasion, proliferation and nuclear regulation

  2004cited by this paper
• Changes in Androgen Receptor Nongenotropic Signaling Correlate with Transition of LNCaP Cells to Androgen Independence

  2004cited by this paper
• Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.

  2004cited by this paper
• Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc.

  2004cited by this paper
• Nonendocrine Pathways and Endocrine Resistance

  2004cited by this paper
• Potential Role of a Novel Transcriptional Coactivator PELP1 in Histone H1 Displacement in Cancer Cells

  2004cited by this paper
• The biological role of estrogen receptors alpha and beta in cancer.

  2004cited by this paper
• p21-activated Kinase-1 Signaling Mediates Cyclin D1 Expression in Mammary Epithelial and Cancer Cells*

  2004cited by this paper
• Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways.

  2004cited by this paper
• Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway.

  2004cited by this paper
• Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer.

  2004cited by this paper
• Upstream Determinants of Estrogen Receptor-α Regulation of Metastatic Tumor Antigen 3 Pathway*

  2004cited by this paper
• Functional Interactions between the Estrogen Receptor Coactivator PELP1/MNAR and Retinoblastoma Protein*

  2003cited by this paper
• Oestrogen Receptor-Mediated Modulation of the EGFR/MAPK Pathway in Tamoxifen-Resistant MCF-7 Cells

  2003cited by this paper
• Biology of the p21-activated kinases.

  2003cited by this paper
• Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response.

  2003cited by this paper
• Emerging functions of p21‐activated kinases in human cancer cells

  2002cited by this paper
• A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm

  2002cited by this paper
• Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade

  2002cited by this paper
• A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm.

  2002cited by this paper
• P21‐activated kinase‐1 phosphorylates and transactivates estrogen receptor‐α and promotes hyperplasia in mammary epithelium

  2002cited by this paper
• Molecular and pharmacological aspects of antiestrogen resistance.

  2001cited by this paper
• Endocrine therapy in the treatment of metastatic breast cancer.

  2001cited by this paper
• Molecular Cloning and Characterization of PELP1, a Novel Human Coregulator of Estrogen Receptor α

  2001cited by this paper
• Etk/Bmx Tyrosine Kinase Activates Pak1 and Regulates Tumorigenicity of Breast Cancer Cells*

  2001cited by this paper
• Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.

  2001cited by this paper
• Cellular and molecular pharmacology of antiestrogen action and resistance.

  2001cited by this paper
• Nuclear receptor conformation, coregulators, and tamoxifen-resistant breast cancer.

  2000cited by this paper
• Tumor metastasis‐associated human MTA1 gene: Its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides

  2000cited by this paper
• Regulatable Expression of p21-activated Kinase-1 Promotes Anchorage-independent Growth and Abnormal Organization of Mitotic Spindles in Human Epithelial Breast Cancer Cells*

  2000cited by this paper
• Regulation of Microfilament Reorganization and Invasiveness of Breast Cancer Cells by Kinase Dead p21-activated Kinase-1*

  2000cited by this paper
• Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor

  2000cited by this paper
• Nongenomic actions of steroid hormones in reproductive tissues.

  1998cited by this paper
• Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain.

  1996cited by this paper
• Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro.

  1995cited by this paper

• Current Therapeutic Opportunities for Estrogen Receptor Mutant Breast Cancer

  2024cites this paper
• Overview of the therapeutic strategies for ER positive breast cancer.

  2023cites this paper
• Tafazzin mediates tamoxifen resistance by regulating cellular phospholipid composition in ER-positive breast cancer

  2023cites this paper
• Exploring new pathways in endocrine-resistant breast cancer

  2022cites this paper
• Inhibition of Vps34 and p110δ PI3K Impairs Migration, Invasion and Three-Dimensional Spheroid Growth in Breast Cancer Cells

  2022cites this paper
• Modeling breast cancer proliferation, drug synergies, and alternating therapies

  2022cites this paper
• Identification of evodiamine as a suppressor of prostate cancer progression by reducing AR transcriptional activity via targeting Src

  2021cites this paper
• Analysis of the Estrogen Receptor-Associated LncRNA Landscape Identifies a Role for ERLC1 in Breast Cancer Progression

  2021cites this paper
• Tamoxifen resistance mechanisms in breast cancer treatment

  2020cites this paper
• Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer.

  2020cites this paper
• Dysregulation of DNA methylation patterns may identify patients with breast cancer resistant to endocrine therapy: A predictive classifier based on differentially methylated regions

  2019cites this paper
• l-Thyroxine induces thermotolerance in yeast

  2019cites this paper
• The 17-Beta-Estradiol Improves Insulin Sensitivity in a Rapid Estrogen Receptor Alpha-Dependent Manner in an Animal Model of Malnourishment

  2019cites this paper
• Chapter 2 Interaction of Naloxone and Estrogen Receptor in Breast Cancer

  2019cites this paper
• The potential influence of breast cancer estrogen receptors’ distribution on active DNA demethylation

  2019cites this paper
• Advances in targeting epidermal growth factor receptor signaling pathway in mammary cancer.

  2018cites this paper
• Biological Principles and Clinical Application of EGFR Inhibitors in Cancer

  2017cites this paper
• Gene Expression Assays for Early-Stage Hormone Receptor–Positive Breast Cancer: Understanding the Differences

  2017cites this paper
• Estrogen Receptors in Cell Membranes: Regulation and Signaling.

  2017cites this paper
• Crosstalk of TTC5 cofactor and the estrogen receptor in breast cancer

  2017cites this paper
• Transport Across Natural and Modified Biological Membranes and its Implications in Physiology and Therapy

  2017cites this paper
• The effect of Tamoxifen and Fulvestrant on pro-inflammatory markers in oestrogen receptor positive breast cancer

  2016cites this paper
• Whsc1l1 Regulates Estrogen Receptor Activity In Sum44 Breast Cancer Cells

  2016cites this paper
• Nodes-and-connections RNAi knockdown screening: identification of a signaling molecule network involved in fulvestrant action and breast cancer prognosis

  2015cites this paper
• Epigenetics Territory and Cancer

  2015cites this paper
• The exploration of CD44 as a mediator of a drug resistant phenotype in ER+ breast cancer

  2015cites this paper
• New estradiol based 111In complex towards the estrogen receptor

  2015cites this paper
• Epigenetic of Retinoic Acid Receptor β2 Gene in Breast Cancer

  2015cites this paper
• Understanding the functions of the novel oncogene SHON in breast cancer

  2015cites this paper
• The Emerging Role of TPR-Domain Immunophilins in the Mechanism of Action of Steroid Receptors

  2014cites this paper
• Endocrine Resistance in Breast Cancer

  2014cites this paper
• Forkhead-box A1 suppresses the progression of endometrial cancer via crosstalk with estrogen receptor α.

  2014cites this paper
• Drug resistance to targeted therapies: Déjà vu all over again

  2014cites this paper
• Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers

  2014cites this paper
• Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells.

  2014cites this paper
• Significance of ERα, HER2, and CAV1 expression and molecular subtype classification to canine mammary gland tumor

  2014influential citation
• p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion.

  2013cites this paper
• p 21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK 1 / 2 pathway mediated MMP-2 secretion

  2013cites this paper
• Characterising response and resistance mechanisms toFaslodex in breast cancer

  2013cites this paper
• SIGNIFICANCE OF ERα , HER 2 , AND CAV 1 EXPRESSION AND MOLECULAR SUBTYPE CLASSIFICATION TO CANINE MAMMARY GLAND TUMOR Submitted

  2013cites this paper
• Clinical biomarkers of response to neoadjuvant endocrine therapy in breast cancer: exploring the potential of gene expression data integration

  2013cites this paper
• Interaction of Naloxone and Estrogen Receptor in Breast Cancer

  2013cites this paper
• Overexpression of p21-activated kinase 1 promotes endometrial cancer progression.

  2013cites this paper
• Exosome-Bound WD Repeat Protein Monad Inhibits Breast Cancer Cell Invasion by Degrading Amphiregulin mRNA

  2013cites this paper
• Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase

  2013cites this paper
• Identification of intermediate risk breast cancer patients with 1-3 positive lymph nodes and excellent survival after tamoxifen as only systemic adjuvant therapy by use of markers of proliferation and apoptosis.

  2013cites this paper
• Characterization of FHL2 expression and function in breast cancer cell lines

  2012cites this paper
• Predicting Prognosis and Tamoxifen Response in Breast Cancer. With a special focus on contralateral breast cancer.

  2012cites this paper
• Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration

  2012cites this paper
• δEF1 Down-Regulates ER-α Expression and Confers Tamoxifen Resistance in Breast Cancer

  2012cites this paper
• Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy

  2011cites this paper
• Expression of NHERF1 in Colonic Tumors Induced by 1,2-dimethylhydrazine in Rats is Independent of Plasma Ovarian Steroids

  2011cites this paper
• Biological mechanisms and clinical implications of endocrine resistance in breast cancer.

  2011cites this paper
• Cell Cycle Regulatory Roles of Estrogen Receptor alpha (ERα) in Breast Cancer Cells

  2011cites this paper
• Breaking the cycle: An insight into the role of ERα in eukaryotic cell cycles

  2011cites this paper
• Significance of ER–Src axis in hormonal therapy resistance

  2011cites this paper
• Significance of ER-Src axis in hormonal therapy resistance

  2011cites this paper
• Endocrine Resistance and Epithelial Mesenchymal Transition in Breast Cancer

  2011cites this paper
• The role of estrogen and estrogen receptors in chemoresistance.

  2011cites this paper
• Cytoplasmic Estrogen Receptor in Breast Cancer

  2011cites this paper
• Signalling pathways involved in endocrine resistance in breast cancer and associations with epithelial to mesenchymal transition (Review).

  2011cites this paper
• Artemin: from neurotrophic factor to oncogene in human mammary carcinoma

  2011cites this paper
• Hormonal Resistance And Metastasis ER-Coregulartor-Src Signaling Targeted Therapy

  2010cites this paper
• Award Number: W81XWH-08-1-0604 TITLE: Hormonal Resistance and Metastasis: ER-coregulator-Src Signaling Targeted therapy

  2010cites this paper
• Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility.

  2010cites this paper
• Prolylcarboxypeptidase Regulates Proliferation, Autophagy, and Resistance to 4-Hydroxytamoxifen-induced Cytotoxicity in Estrogen Receptor-positive Breast Cancer Cells*

  2010cites this paper
• Extranuclear signaling by estrogen: role in breast cancer progression and metastasis.

  2010cites this paper
• Molecular Cross-Talk Between Nuclear Receptors and Nuclear Factor-κB

  2010cites this paper
• Cell proliferation regulated by estradiol receptor: Therapeutic implications.

  2010cites this paper
• Regulation of aromatase induction by nuclear receptor coregulator PELP1.

  2010cites this paper
• Biological determinants of endocrine resistance in breast cancer

  2009cites this paper
• Hormonal Resistance and Metastasis: ER-coregulator-Src Targeted Therapy

  2009cites this paper
• PELP1: A novel therapeutic target for hormonal cancers

  2009cites this paper
• Signaling-dependent nuclear export of estradiol receptor controls cell cycle progression in breast cancer cells.

  2009cites this paper
• The Presence of Nonnuclear Estrogen Receptor-alpha in Breast Cancer and Its Prognostic/Predictive Value

  2009cites this paper
• Effects of Celecoxib and Ly117018 Combination on Human Breast Cancer Cells in Vitro

  2009cites this paper
• Cancer Therapy : Preclinical Extranuclear Coactivator Signaling Confers Insensitivity to Tamoxifen

  2009cites this paper
• Estradiol-regulated microRNAs control estradiol response in breast cancer cells

  2009cites this paper
• Expression of ER- 36, a Novel Variant of Estrogen Receptor , and Resistance to Tamoxifen Treatment in Breast Cancer

  2009cites this paper
• Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.

  2009cites this paper
• Extranuclear Coactivator Signaling Confers Insensitivity to Tamoxifen

  2009cites this paper
• Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells

  2008cites this paper
• Rational management of endocrine resistance in breast cancer

  2008cites this paper
• Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.

  2008cites this paper
• Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors

  2008cites this paper
• Molecular Targets of Breast Cancer: AKTing in Concert

  2008cites this paper
• Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer

  2008cites this paper
• Do microRNAs Mediate Estrogen-Dependent Repression of Genes

  2008cites this paper
• MTA1 Promotes Autophagy and Resistance to Tamoxifen in ERα-Positive Breast Cancer Cell Line

  2008cites this paper
• Regulation of estrogenic effects by beclin 1 in breast cancer cells.

  2008cites this paper
• Activity of Estrogen Receptor-A via Covalent Modification of DNA-Binding Domain

  2007cites this paper
• 15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain.

  2007cites this paper
• Nongenomic Actions of Aldosterone on the Renal Tubule

  2007cites this paper
• Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.

  2007cites this paper
• SUMO and estrogen receptors in breast cancer

  2007cites this paper
• Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism

  2007cites this paper
• Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer

  2007cites this paper
• Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR

  2007cites this paper
• Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.

  2007cites this paper
• Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment.

  2007cites this paper